ESR1 and breast carcinoma: For instance, over-expression of zinc transporter ZIP6 has been noted in estrogen receptor positive (ER+) subtypes and is related to less aggressive tumors [13], and ZIP10 have been shown to be involved in invasive behavior of breast cancer cells [14].